Table 2.
Association Between miR-17-5p Expression and Clinicopathological Parameters in 110 Patients With Glioma
| Parameters | Total (n) | miR-17-5p Expression | p Value | |
|---|---|---|---|---|
| High [n (%)] | Low [n (%)] | |||
| Total | 110 | 27 (24.54545455) | 83 (75.45454545) | |
| Age | 0.75303 (NS) | |||
| <60 | 42 | 11 (26.19047619) | 31 (73.80952381) | |
| >60 | 68 | 16 (23.52941176) | 52 (76.47058824) | |
| Gender | 0.83018 (NS) | |||
| Male | 51 | 13 (25.49019608) | 38 (74.50980392) | |
| Female | 59 | 14 (23.72881356) | 45 (76.27118644) | |
| Clinical stage | 0.00189 | |||
| I–II | 57 | 21 (36.84210526) | 36 (63.15789474) | |
| III–IV | 53 | 6 (11.32075472) | 47 (88.67924528) | |
| Relapse | 0.01089 | |||
| No | 54 | 19 (35.18518519) | 35 (64.81481481) | |
| Yes | 56 | 8 (14.28571429) | 48 (85.71428571) | |
| Tumor differentiation | 0.00028 | |||
| Well | 41 | 18 (43.90243902) | 23 (56.09756098) | |
| Moderate | 69 | 9 (13.04347826) | 60 (86.95652174) | |
NS, not significant.